HIMS – Hims & Hers Health Inc.

Latest News & Stock Analysis

Hims & Hers Health Inc. (HIMS) is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, offering personalized treatment plans for a variety of conditions, including sexual health, hair loss, dermatology, and mental health. The company distinguishes itself through its direct-to-consumer approach, leveraging technology to provide convenient and affordable access to healthcare. Hims & Hers is innovating in the telehealth space by expanding its range of services and focusing on personalized, accessible care, making it a notable stock for investment and closely watched for market trends.

HIMS Hits Key Support: Buy the Dip in This Growth Stock?
HIMS

HIMS Hits Key Support: Buy the Dip in This Growth Stock?

by | 15/04/2025 10:00 AM | HIMS

📉 HIMS stock has fallen significantly but is now testing a crucial long-term support level (40-week/200-day moving average), potentially offering an attractive entry point for investors monitoring technical levels.

💰 HIMS boasts impressive fundamentals, including strong revenue growth (77-95% recent quarterly growth), expected future profit increases (117% in 2025, 46% in 2026), and increasing institutional ownership, signaling underlying business strength.

🛡️ As a US-focused online pharmacy platform disrupting the sector, HIMS appears largely insulated from the direct impacts of the current tariff war, reducing a key market risk.

Read more!